HIMS vs Peers Stock Comparison

Hims & Hers Health Prices as of Oct 26, 2026 Peers: Industry group

Percentile Scorecard

HIMS

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisHIMS
Valuation 34 #62 of 93
Growth 41 #52 of 88
Profitability 40 #53 of 87
Financial Health 20 #80 of 100
Shareholder Returns 66 #20 of 56
Overall 40
  • HIMS ranked among 103 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodHIMSSPY
1 month -6.3% -0.8%
3 months -8.8% +3.5%
6 months -6.2% +7.0%
Year to date -15.1% +12.2%
1 year -43.5% +13.0%
3 years +377.2% +86.3%
3 years, per year +68.4% +23.1%
5 years +270.7% +68.6%
5 years, per year +30.0% +11.0%

Risk

MeasureHIMSSPY
Volatility, 1Y 86.9% 12.7%
Downside volatility, 1Y 79.0% 12.7%
Beta vs S&P 500, 1Y 2.78 1.00
Return / volatility, 1Y -0.50 1.02
Max drawdown, 5Y -78.9% -25.4%
From 52-week high -42.8% -1.8%
52-week high $48.23 $779.14
52-week low $14.52 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleHIMS
P/E now vs peer median -45.0xmedian 25.1x
P/S now vs peer median 2.5xmedian 1.6x
EV/EBITDA now vs peer median -92.9xmedian 14.5x
P/FCF now vs peer median 77.5xmedian 22.4x
P/B now vs peer median 19.9xmedian 3.1x
PEG now vs peer median 1.14median 0.66

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsHIMS
Revenue $2.58B
Gross profit $1.76B
Operating income -$154.52M
Net income -$142.00M
Free cash flow $83.03M
R&D $183.38M
EPS (diluted) $-0.61
Cash & equivalents $609.81M
Shares (diluted) 231.75M
Enterprise value $3.68B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricHIMS
P/E -45.0x
P/FCF 77.5x
P/Operating cash flow 24.4x
P/S 2.5x
P/B 19.9x
P/Tangible book -65.2x
EV/EBITDA -92.9x
EV/EBIT -36.2x
EV/Revenue 2.2x
EV/FCF 67.4x
EV/Operating cash flow 21.2x
PEG (3Y EPS CAGR) 1.14

Growth

14 metrics
MetricHIMS
Revenue growth (1Y) 28.0%
Revenue CAGR (3Y) 53.7%
Gross profit growth (1Y) 15.0%
Gross profit CAGR (3Y) 45.7%
Operating income growth (1Y) -223.0%
Operating income CAGR (3Y) -43.7%
Net income growth (1Y) -173.3%
Net income CAGR (3Y) -44.6%
EPS growth (1Y) -181.3%
EPS CAGR (3Y) -39.6%
Operating cash flow growth (1Y) 0.7%
Operating cash flow CAGR (3Y) 117.6%
Free cash flow growth (1Y) -37.3%
Free cash flow CAGR (3Y) 67.0%

Profitability

14 metrics
MetricHIMS
Gross margin 68.4%
EBITDA margin -2.3%
Operating margin -6.0%
Pretax margin -6.3%
Net margin -5.5%
FCF margin 3.2%
Operating cash flow margin 10.2%
Return on equity -36.9%
Return on assets -4.8%
Return on invested capital –
Return on capital employed -10.5%
Asset turnover 0.9x
Cash conversion (OCF / net income) -1.9x
Stock comp / revenue 6.0%

Financial Health

11 metrics
MetricHIMS
Debt / assets –
Debt / equity –
Net debt / EBITDA –
Debt / FCF –
Liabilities / assets 91.1%
Equity / assets 8.9%
Interest coverage –
Current ratio 0.9x
Quick ratio 0.8x
Cash ratio 0.6x
Altman Z-score 1.59

Shareholder Returns

7 metrics
MetricHIMS
Dividend yield –
Net buyback yield 1.0%
Shareholder yield 1.0%
Payout ratio (earnings) –
Payout ratio (FCF) –
Dividend growth (1Y) –
Dividend CAGR (3Y) –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusHIMS
EPS, next fiscal year $-0.62FY2026
EPS growth, next FY -221.6%FY2026
Revenue, next fiscal year $3.34BFY2026
Revenue growth, next FY +42.0%FY2026
Revenue growth, the year after +28.1%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersHIMS
Held by institutions 66.8%
Institutions holding 508
Change in shares held, QoQ +4.5%
Institutions buying 324
Institutions selling 129
Buyers to sellers 2.51

Add a Peer

Largest companies in the same industry

Related Comparisons

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.